Handa filings that have been approved by U.S. FDA include:

● PHYRAGOTM (Handa Therapeutics, LLC)
● TASCENSO ODT® (Cycle Pharmaceuticals)
● Dexlansoprazole Delayed-Release Capsules (Par Pharmaceutical)
● Quetiapine Fumarate Extended-Release Tablets (Par Pharmaceutical)

 

Handa filings that have been approved by Health Canada include:

● Quetiapine Fumarate Extended-Release Tablets (ANDS in Partner’s name)